Arcutis Biotherapeutics I...
13.67
0.39 (2.94%)
At close: Jan 15, 2025, 11:46 AM

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Net Income -262.14M -311.46M -206.36M -135.68M -42.00M -19.25M -4.98M
Depreciation & Amortization 1.52M 934.00K 454.00K 122.00K 195.00K n/a n/a
Stock-Based Compensation 38.81M 32.68M 23.89M 7.94M 824.00K 151.00K 27.00K
Other Working Capital -3.68M 4.23M 3.38M 8.46M -1.05M 844.00K -258.00K
Other Non-Cash Items -1.75M 30.30M 309.00K 333.00K -354.00K 2.91M 897.00K
Deferred Income Tax n/a n/a 3.45M 114.00K n/a n/a n/a
Change in Working Capital -23.50M -10.18M 3.62M 14.13M -1.50M 2.11M 279.00K
Operating Cash Flow -247.06M -257.71M -174.63M -113.03M -42.84M -14.09M -3.77M
Capital Expenditures -428.00K -23.28M -995.00K -321.00K -295.00K n/a n/a
Acquisitions n/a 22.95M 74.96M 181.50M 26.03M n/a n/a
Purchase of Investments -225.84M -415.39M -292.51M -279.10M -60.83M -11.53M n/a
Sales Maturities Of Investments 406.50M 351.47M 217.55M 97.60M 34.80M n/a n/a
Other Investing Acitivies n/a -22.95M -74.96M -181.50M -26.03M -11.53M n/a
Investing Cash Flow 180.23M -87.20M -75.95M -181.82M -26.32M -11.53M n/a
Debt Repayment n/a 125.00M 73.99M n/a n/a n/a 50.00K
Common Stock Repurchased n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies 2.42M 751.00K 470.00K 1.14M 93.10M 61.59M 14.14M
Financial Cash Flow 101.32M 301.80M 281.95M 298.14M 93.10M 61.59M 7.12M
Net Cash Flow 34.45M -43.12M 31.37M 3.29M 23.94M 35.98M 3.34M
Free Cash Flow -247.49M -281.00M -175.62M -113.35M -43.13M -14.09M -3.77M

Create Price Alert on ARQT

Your price alert will notify you when the stock price is above 13.67.

Add to Watchlist